Shalby
Shalby Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Shalby Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Shalby Ltd trades at a P/E of 52.97× and P/B of 1.82×.
Valuation
Profitability
Growth
Financial Health
Shalby Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Shalby Ltd, switchable between annual and quarterly views, consolidated or standalone.
Shalby Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,854.1 Cr and reported EPS of ₹3.24.
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 383 | 383 | 461 | 487 | 431 | 699 | 805 | 934 | 1,087 | 1,141 |
| Other Income | 9 | 9 | 10 | 17 | 9 | 12 | 23 | 19 | 28 | 27 |
| Total Income | 392 | 392 | 471 | 504 | 440 | 711 | 827 | 953 | 1,115 | 1,168 |
| Cost of Goods Sold (COGS) | 39 | 39 | 112 | 125 | 104 | 174 | 196 | 64 | 115 | 151 |
| Gross Profit | 344 | 344 | 349 | 362 | 327 | 525 | 609 | 870 | 972 | 990 |
| +Operating Expenses | 261 | 261 | 268 | 280 | 241 | 405 | 472 | 693 | 840 | 847 |
| EBITDA | 83 | 83 | 81 | 82 | 86 | 120 | 137 | 177 | 133 | 143 |
| +Non-Operating Expenses | 35 | 35 | 40 | 42 | 40 | 44 | 57 | 68 | 104 | 109 |
| Profit Before Tax (PBT) | 57 | 57 | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 61 |
| +Tax Expense | 15 | 15 | 19 | 29 | 13 | 25 | 34 | 45 | 54 | 26 |
| Profit After Tax (PAT) | 43 | 43 | 32 | 28 | 42 | 54 | 68 | 83 | 2 | 35 |
| Earnings Per Share (EPS) | 3.97 | 3.97 | 2.93 | 2.55 | 3.93 | 5.00 | 6.27 | 7.73 | 0.58 | 3.46 |
| Diluted Shares Outstanding (Nos.) | 15 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| +Additional Disclosures | 374 | 374 | 533 | 573 | 489 | 802 | 923 | 889 | 1,167 | 1,232 |
| Sales Growth % | — | — | 20.28 | 5.62 | -11.49 | 62.21 | 15.16 | 16.01 | 16.41 | 5.01 |
| YoY Sales Growth % | — | — | 20.28 | 5.62 | -11.49 | 62.21 | 15.16 | 16.01 | 16.41 | 5.01 |
| Material Cost % | — | — | 15 | 15 | 16 | 19 | 21 | 3 | 9 | 6 |
| Employee Cost % | 12 | 12 | 14 | 13 | 13 | 17 | 18 | 17 | 17 | 16 |
| Other Cost % | 56 | 56 | 44 | 44 | 43 | 41 | 41 | 58 | 60 | 58 |
| OPM % | 22 | 22 | 18 | 17 | 20 | 17 | 17 | 19 | 12 | 13 |
| Tax % | 25 | 25 | 37 | 51 | 23 | 32 | 34 | 35 | 97 | 43 |
| Profit Growth % | — | — | -25.89 | -12.85 | 53.56 | 27.40 | 25.40 | 23.38 | -97.70 | 1,706.61 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 61 | 61 | 48 | 46 | 50 | 77 | 89 | 125 | 67 | 73 |
Shalby segment analysis: revenue and profit mix.
Disclosed business segments at Shalby with their share of revenue and profit, switchable between consolidated and standalone reporting.
Shalby discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Shalby Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Shalby Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Shalby Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding (74.3%) indicates firm confidence in long-term prospects.
Sustained revenue growth with 5-year CAGR of 17.43% is positive.
Operates in resilient healthcare sector, offering significant long-term growth potential.
Positive quarterly sales growth of 6.29% indicates healthy top-line expansion.
Integrated business model includes hospitals, implant manufacturing, and education.
What can break it.
Significant quarterly profit decline of -43.00% signals operational challenges.
Reported net loss of -0.52 Cr and negative TTM EPS -0.28.
Notably low Return on Equity (0.62%) indicates inefficient capital utilization.
Negative cash flow per share (-7.05) raises liquidity concerns.
Unsustainable payout ratio (381.88% TTM) given current negative earnings.
What would change my mind.
Trim if P/E re-rates above 69. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 59.62. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Shalby Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Shalby Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Shalby Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Shalby Ltd — derived from the live tape, not yesterday's close.
Shalby Ltd last traded at ₹170.46 with an intraday range of ₹169.1–₹173.43 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹170.46| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 181.55 | +11.09 | +6.51% |
| R3 | 177.22 | +6.76 | +3.97% |
| R2 | 175.33 | +4.87 | +2.86% |
| R1 | 172.89 | +2.43 | +1.43% |
| PIVOT | 171.00 | 0.54 | 0.31% |
| CURRENT | 170.46 | — | — |
| S1 | 159.90 | -10.56 | -6.19% |
| S2 | 164.23 | -6.23 | -3.65% |
| S3 | 166.67 | -3.79 | -2.23% |
| S4 | 168.56 | -1.90 | -1.11% |
SHALBY is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 172.25 ~ 173.43
Trading Inside opening range
Shalby Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Shalby Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Shalby Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Shalby Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Shalby Ltd stood at 53.5% of traded volume, against a 20-day average of 47.6%.
Shalby announcements: results, concalls, ratings, M&A.
Filings Shalby sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Shalby files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 93 documents below.
Disclosure under SEBI Takeover Regulations
Shalby Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Copy of Newspaper Publication
Shalby Limited has informed the Exchange about Copy of Newspaper Publication
Analysts/Institutional Investor Meet/Con. Call Updates
Shalby Limited has informed the Exchange about Earnings Conference Call scheduled on May 29, 2026 at 05:00 pm. IST to discuss Q4 FY 2026 earnings
Updates
Shalby Limited has informed the Exchange regarding 'Exercise of Employee Stock Options under Shalby Limited Employees Stock Options Scheme-2021'.
Investor decks & rating reports.
Shalby dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Shalby has declared, sequenced by announce and record date.
Shalby corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Shalby Ltd: business, sector, key facts.
What Shalby Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Shalby Ltd operates in the Healthcare, listed as NSE: SHALBY, BSE: 540797.
Shalby Limited is a multinational healthcare company with a significant presence in India and expanding operations internationally, including the United States, Japan, Indonesia, Oman, the UAE, Bangladesh, and Nepal. Its core business revolves around the operation of multi-specialty hospitals, providing a wide range of medical services.
The company's Healthcare Services segment encompasses a vast spectrum of medical specializations. This includes surgical procedures such as arthroscopy, arthroplasty, and various types of transplants (liver, organ), along with extensive diagnostic and therapeutic services. The range of specialties is broad, covering cardiology, oncology, neurology, gastroenterology, ophthalmology, orthopedics, and many more. They also offer comprehensive care in areas like emergency medicine, intensive care, and pediatrics. Beyond inpatient care, Shalby provides outpatient services and home healthcare solutions such as ICU at home, nursing care, and physiotherapy.
In addition to its healthcare services, Shalby operates a Manufacturing segment focused on the design, development, and manufacture of orthopedic implants. This vertical integration allows Shalby to control aspects of its supply chain and potentially offer cost-effective solutions within its hospital system.
Shalby further distinguishes itself through its educational initiatives, providing training programs for paramedical students and healthcare professionals. This investment in education and training contributes to the development of skilled healthcare personnel and supports the company's overall growth strategy. In essence, Shalby Limited is a diversified healthcare organization that integrates hospital operations, medical device manufacturing, and educational programs to provide comprehensive healthcare services across various locations globally.
Questions investors ask about Shalby Ltd (SHALBY).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Shalby Ltd (SHALBY)?
The current share price of Shalby Ltd (SHALBY) is ₹170.46. Today, the stock has declined by ₹1.15 (0.67%), trading in a range of ₹169.1 to ₹173.43. The stock opened at ₹172.25 with a trading volume of 58,491 shares.
02Is Shalby Ltd stock a good investment for long-term?
Shalby Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,854.1 crores, P/E ratio of 52.97, ROE of 3.47%, and ROCE of 6.12%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Shalby Ltd stock?
The 52-week high price of Shalby Ltd (SHALBY) is ₹274.7, while the 52-week low is ₹125.82. Currently trading at ₹170.46, the stock is 30.0% away from its 52-week low and 37.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Shalby Ltd stock at the current price?
Whether to buy Shalby Ltd stock at ₹170.46 depends on multiple factors. The stock is currently trading with a P/E ratio of 52.97 and P/B ratio of 1.82. Today's performance shows a loss of 0.67%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Shalby Ltd and when is the next dividend?
Shalby Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹170.46, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Shalby Ltd?
Shalby Ltd's key financial metrics include: P/E Ratio: 52.97, P/B Ratio: 1.82, ROE: 3.47%, ROCE: 6.12%, Dividend Yield: 0.00%, EPS: ₹3.24, Book Value: ₹94.39, and Debt-to-Equity: 59.12. The company's market cap stands at ₹1,854.1 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Shalby Ltd stock performing today in the market?
Shalby Ltd stock opened at ₹172.25 and is currently trading at ₹170.46, showing a decline of ₹1.15 (0.67%). The intraday high is ₹173.43 and low is ₹169.1. The trading volume stands at 58,491 shares, indicating moderate market participation today.
08What is the P/E ratio of Shalby Ltd and what does it indicate?
Shalby Ltd has a Price-to-Earnings (P/E) ratio of 52.97, which means investors are willing to pay ₹52.97 for every ₹1 of earnings. With an EPS of ₹3.24, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Shalby Ltd (SHALBY) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwals Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy